CO7 Patient Reported Outcome Measure for Giant Cell Arteritis: Cross-Sectional Validation Study
Value in Health(2022)
Abstract
Giant cell arteritis (GCA) presents in people over the age of 50 with cranial, ocular, and large vessel vasculitis. This study aims to validate a disease-specific patient reported outcome (PRO) measure for patients with GCA, to capture the impact of GCA and its treatment on health-related quality of life.
MoreTranslated text
Key words
giant cell arteritis,co7 patient,cross-sectional
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined